Ulcerative Colitis Chronic Mild
Immunology
1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Assembly BiosciencesABI-M201
Clinical Trials (1)
ABI-M201 in Adult Subjects With Mildly-to-Moderately Active Ulcerative Colitis
Start: Jun 2019Est. completion: Jan 2021
Phase 1Terminated
Related Jobs in Immunology
Regulatory Affairs Manager(Immunology), Korea
AbbVie
Seoul, Seoul
8h ago
Regional Sales Trainer - Rheumatology (Mid Atlantic/Central)
AbbVie
Remote
9h ago
Senior Area Business Specialist, Immunology - Detroit, MI - Johnson & Johnson Innovative Medicine
Johnson & Johnson
Detroit, Michigan, United States
23h ago
Product Specialist - Immunology
Johnson & Johnson
Kibbutz Shefayim, Center District, Israel
23h ago
Senior Clinical Trial Physician, Rheumatology
Bristol Myers Squibb
Princeton - NJ - US
23h ago
$309K - $374K/yr
Supply Chain and Procurement Controller
Ferring Pharmaceuticals
Hvidovre, Denmark
23h ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space